NCT07057791
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07057791
Title Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer (PrE0510)
Acronym PrE0510
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute RECRUITING New Brunswick New Jersey 08901 United States Details
Montefiore Medical Center- Montefiore Medical Park RECRUITING The Bronx New York 10461 United States Details
Fox Chase Cancer Center RECRUITING Philadelphia Pennsylvania 19111 United States Details
Guthrie RECRUITING Sayre Pennsylvania 18840 United States Details
Universtiy of Virginia RECRUITING Charlottesville Virginia 22908 United States Details
Aspirus Cancer Center Wausau RECRUITING Wausau Wisconsin 54401 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field